BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pierik M, Rutgeerts P, Vlietinck R, Vermeire S. Pharmacogenetics in inflammatory bowel disease. World J Gastroenterol 2006; 12(23): 3657-3667 [PMID: 16773681 DOI: 10.3748/wjg.v12.i23.3657]
URL: https://www.wjgnet.com/1007-9327/full/v12/i23/3657.htm
Number Citing Articles
1
Ignacio Rego-Pérez, Mercedes Fernández-Moreno, Vanessa Carreira-García, Francisco J. Blanco. Gene polymorphisms and pharmacogenetics in rheumatoid arthritisReumatología Clínica (English Edition) 2009; 5(6): 268 doi: 10.1016/S2173-5743(09)70135-2
2
Ferenc Nagy, Tamás Molnár, Zoltán Szepes, Klaudia Farkas, Tibor Nyári, János Lonovics. Efficacy of 6-mercaptopurine treatment after azathioprine hypersensitivity in inflammatory bowel diseaseWorld Journal of Gastroenterology 2008; 14(27): 4342-4346 doi: 10.3748/wjg.14.4342
3
Trilokraj Tejasvi, Philip E. Stuart, Vinod Chandran, John J. Voorhees, Dafna D. Gladman, Proton Rahman, James T. Elder, Rajan P. Nair. TNFAIP3 Gene Polymorphisms Are Associated with Response to TNF Blockade in PsoriasisJournal of Investigative Dermatology 2012; 132(3): 593 doi: 10.1038/jid.2011.376
4
Kalpesh K. Patel, Mark W. Babyatsky. Medical Education: A Key Partner in Realizing Personalized Medicine in GastroenterologyGastroenterology 2008; 134(3): 656 doi: 10.1053/j.gastro.2008.01.064
5
Cath Stansfeld. Making sense of metabolites, azathioprine and allopurinol in IBDGastrointestinal Nursing 2012; 10(2): 24 doi: 10.12968/gasn.2012.10.2.24
6
Rinse K Weersma, Cisca Wijmenga. Using genetic information for the identification, classification and treatment of Crohn’s disease: are we there yet?Expert Review of Gastroenterology & Hepatology 2008; 2(6): 719 doi: 10.1586/17474124.2.6.719
7
Ignacio Rego-Pérez, Mercedes Fernández-Moreno, Vanessa Carreira-García, Francisco J. Blanco. Polimorfismos genéticos y farmacogenética en la artritis reumatoideReumatología Clínica 2009; 5(6): 268 doi: 10.1016/j.reuma.2008.12.001
8
Marc R Fournier, Julianne Klein, Gerald Y Minuk, Charles N Bernstein. Changes in Liver Biochemistry During Methotrexate Use for Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology 2010; 105(7): 1620 doi: 10.1038/ajg.2010.21
9
Giovanni Latella, Claudio Fiocchi, Renzo Caprilli. Late-breaking news from the “4th International Meeting on Inflammatory Bowel Diseases” Capri, 2006Inflammatory Bowel Diseases 2007; 13(8): 1031 doi: 10.1002/ibd.20127
10
Islam M. Ibrahim, Hanan S. Althagafy, Esraa K. Abd-alhameed, W.S. Al-Thubiani, Emad H.M. Hassanein. Promising hepatoprotective effects of lycopene in different liver diseasesLife Sciences 2022; 310: 121131 doi: 10.1016/j.lfs.2022.121131
11
Michael Eberhardson, Charlotte R. H. Hedin, Marie Carlson, Laura Tarnawski, Yaakov A. Levine, Peder S. Olofsson. Towards improved control of inflammatory bowel diseaseScandinavian Journal of Immunology 2019; 89(3) doi: 10.1111/sji.12745
12
C.R.H. Hedin, E. Sonkoly, M. Eberhardson, M. Ståhle. Inflammatory bowel disease and psoriasis: modernizing the multidisciplinary approachJournal of Internal Medicine 2021; 290(2): 257 doi: 10.1111/joim.13282
13
Kalliopi P. Spyridopoulou, Niki L. Dimou, Stavros J. Hamodrakas, Pantelis G. Bagos. Methylene tetrahydrofolate reductase gene polymorphisms and their association with methotrexate toxicityPharmacogenetics and Genomics 2012; 22(2): 117 doi: 10.1097/FPC.0b013e32834ded2a
14
Ruta Steponaitiene, Juozas Kupcinskas, Santa Survilaite, Greta Varkalaite, Laimas Jonaitis, Gediminas Kiudelis, Goda Denapiene, Jonas Valantinas, Jurgita Skieceviciene, Limas Kupcinskas. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effectsAdvances in Medical Sciences 2016; 61(1): 135 doi: 10.1016/j.advms.2015.09.008
15
Rocio Sanchez, Emile Levy, Florin Costea, Daniel Sinnett. IL-10 and TNF-α promoter haplotypes are associated with childhood Crohn’s disease locationWorld Journal of Gastroenterology 2009; 15(30): 3776-3782 doi: 10.3748/wjg.15.3776
16
WANSHENG LAO, MEIYUN FANG, XIFEI YANG. FK506-binding protein 51 (FKBP5) gene polymorphism is not associated with glucocorticoid therapy outcome in patients with idiopathic thrombocytopenic purpuraMolecular Medicine Reports 2012; 6(4): 787 doi: 10.3892/mmr.2012.993
17
Javier P. Gisbert, Fernando Gomolln. Thiopurine-Induced Myelotoxicity in Patients With Inflammatory Bowel Disease: A ReviewThe American Journal of Gastroenterology 2008; 103(7): 1783 doi: 10.1111/j.1572-0241.2008.01848.x
18
Csilla Sipeky, Anita Maász, Gréta Tarlós, Katalin Komlósi, Éva Pollák, Béla Melegh. Importance of thiopurine s-methyltransferase gene testOrvosi Hetilap 2012; 153(5): 191 doi: 10.1556/OH.2012.29289
19
Edna Efrati, Lior Adler, Norberto Krivoy, Eli Sprecher. Distribution of TPMT risk alleles for thioupurine toxicity in the Israeli populationEuropean Journal of Clinical Pharmacology 2009; 65(3): 257 doi: 10.1007/s00228-008-0590-7
20
Marco Castori, Paola Grammatico. Crohn’s Disease2010; : 17 doi: 10.1007/978-88-470-1472-5_3
21
Patricia L Kozuch, Stephen B Hanauer. Treatment of inflammatory bowel disease: A review of medical therapyWorld Journal of Gastroenterology 2008; 14(3): 354-377 doi: 10.3748/wjg.14.354
22
Kalle Landerholm, Disa Kalman, Conny Wallon, Pär Myrelid. Immunomodulators: Friends or Enemies in Surgery for Crohn’s Disease?Current Drug Targets 2019; 20(13): 1384 doi: 10.2174/1389450120666190617163919
23
Dana Duricova, Natalia Pedersen, Martin Lenicek, Christian Jakobsen, Milan Lukas, Vibeke Wewer, Pia Munkholm. The clinical implication of drug dependency in children and adults with inflammatory bowel disease: A reviewJournal of Crohn's and Colitis 2011; 5(2): 81 doi: 10.1016/j.crohns.2010.12.006
24
Nancy Benight, Douglas G. Burrin, Barbara Stoll. Glutathione and Sulfur Amino Acids in Human Health and Disease2009; : 47 doi: 10.1002/9780470475973.ch4
25
Jeeshan Chowdhury, Govind V. Kagiala, Sudeep Pushpakom, Jana Lauzon, Alistair Makin, Alexey Atrazhev, Alex Stickel, William G. Newman, Christopher J. Backhouse, Linda M. Pilarski. Microfluidic Platform for Single Nucleotide Polymorphism Genotyping of the Thiopurine S-Methyltransferase Gene to Evaluate Risk for Adverse Drug EventsThe Journal of Molecular Diagnostics 2007; 9(4): 521 doi: 10.2353/jmoldx.2007.070014
26
Jayshri A. Shah, Cathryn M. Edwards, Chris S. Probert. Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcomeEuropean Journal of Gastroenterology & Hepatology 2008; 20(3): 169 doi: 10.1097/MEG.0b013e3282f16d50
27
S. Bonnet Ducrot, D. Plantaz, N. Mathieu, T. Debillon, C. Bost Bru, M.-P. Brenier-Pinchart, H. Fricker-Hidalgo, M. Chevallier. Neonatal fever: A puzzling caseArchives de Pédiatrie 2018; 25(7): 435 doi: 10.1016/j.arcped.2018.08.004
28
Experimental and Clinical Transplantation 2023; 21(8) doi: 10.6002/ect.2023.0066
29
Waseem Younis Khan, Farhat Jabeen, Nuzhat Khursheed, Bashir Ahmad Malla, Aarif Ali, Showkat Ahmad Ganie. Pharmacogenomics2023; : 271 doi: 10.1016/B978-0-443-15336-5.00011-7
30
Johan Van Limbergen, Richard K. Russell, Elaine R. Nimmo, Jack Satsangi. The Genetics of Inflammatory Bowel DiseaseThe American Journal of Gastroenterology 2007; 102(12): 2820 doi: 10.1111/j.1572-0241.2007.01527.x
31
Fraser Smith. Naturopathic Medicine2022; : 225 doi: 10.1007/978-3-031-13388-6_8
32
Amosy E. M'Koma, Paul E. Wise, David A. Schwartz, Roberta L. Muldoon, Alan J. Herline. Prevalence and Outcome of Anemia After Restorative ProctocolectomyDiseases of the Colon & Rectum 2009; 52(4): 726 doi: 10.1007/DCR.0b013e31819ed571
33
Victoria A. Joshi, Raju Kucherlapati. Genetics and Genomics in the Practice of MedicineGastroenterology 2008; 134(5): 1284 doi: 10.1053/j.gastro.2008.03.046
34
Yang Wang, Yimin Li, Yun Liu, Yifan Zhang, Ziliang Ke, Yu Zhang, Yulan Liu. Patients With IBD Receiving Methotrexate Are at Higher Risk of Liver Injury Compared With Patients With Non-IBD Diseases: A Meta-Analysis and Systematic ReviewFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.774824
35
Paraskevi Nani, Melpomeni Ladopoulou, Evgenia H. Papaioannou, Evangelia D. Papagianni, Charalabos Antonatos, Panagiotis Xiropotamos, Andreas Kapsoritakis, Petros S. Potamianos, Konstantinos Karmiris, Charalambos Tzathas, Aikaterini Patsatsi, Elisavet Lazaridou, Efterpi Zafiriou, Angeliki Roussaki-Schulze, Sophia Georgiou, Katerina Grafanaki, Georgios K. Georgakilas, Yiannis Vasilopoulos. Pharmacogenetic Analysis of the MIR146A rs2910164 and MIR155 rs767649 Polymorphisms and Response to Anti-TNF Treatment in Patients with Crohn’s Disease and PsoriasisGenes 2023; 14(2): 445 doi: 10.3390/genes14020445